title: Severe delayed hemolysis associated with regulated parenteral antimalarial drug.
authors.forename: Julia
authors.initials: J
authors.lastname: Lee
authors.forename: Sigmund
authors.initials: S
authors.lastname: Krajden
authors.forename: Christopher
authors.initials: C
authors.lastname: Graham
authors.forename: Andrea K
authors.initials: AK
authors.lastname: Boggild
authors.forename: Katerina
authors.initials: K
authors.lastname: Pavenski
authors.forename: Jay S
authors.initials: JS
authors.lastname: Keystone
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Kain
mesh_terms: D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000175:diagnosis*; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects*; D037621:Artemisinins / Q000008:administration & dosage / Q000009:adverse effects*; D000077332:Artesunate; D004333:Drug Administration Routes; D006461:Hemolysis; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D016778:Malaria, Falciparum / Q000188:drug therapy; D008297:Male
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate